Elevated expression of miR-204-5p depresses NSCLC migration and invasion by targeting Janus kinase 2 (JAK2) [17], restrains proliferation of NSCLC cells by regulating SIX homeobox 1 (SIX1) and attenuates LUAD angiogenesis potentially by JAK2-signal transducer and activator of transcription 3 (JAK2-STAT3) pathway [16]. The gene discussed is JAK2; the disease is non-small cell lung carcinoma.